ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

NCAB Approves New Grant Award Honoring Howard Temin

March 8, 1996

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989